trazodone has been researched along with Disruptive, Impulse Control, and Conduct Disorders in 1 studies
Trazodone: A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309)
trazodone : An N-arylpiperazine in which one nitrogen is substituted by a 3-chlorophenyl group, while the other is substituted by a 3-(3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)propyl group.
Disruptive, Impulse Control, and Conduct Disorders: Disorders whose essential features are the failure to resist an impulse, drive, or temptation to perform an act that is harmful to the individual or to others. Individuals experience an increased sense of tension prior to the act and pleasure, gratification or release of tension at the time of committing the act.
Excerpt | Relevance | Reference |
---|---|---|
"We describe three patients with concurrent DSM-III-R kleptomania and bulimia nervosa who all demonstrated a partial or complete response of both bulimic and kleptomanic symptoms to fluoxetine, trazodone, or tranylcypromine." | 5.06 | Pharmacological treatment of kleptomania and bulimia nervosa. ( Hudson, JI; Keck, PE; McElroy, SL; Pope, HG, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
McElroy, SL | 1 |
Keck, PE | 1 |
Pope, HG | 1 |
Hudson, JI | 1 |
1 trial available for trazodone and Disruptive, Impulse Control, and Conduct Disorders
Article | Year |
---|---|
Pharmacological treatment of kleptomania and bulimia nervosa.
Topics: Adult; Bulimia; Clinical Trials as Topic; Disruptive, Impulse Control, and Conduct Disorders; Drug T | 1989 |